3841 studies found for:    "Slow Virus Diseases"
Show Display Options
Rank Status Study
1 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
2 Recruiting Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
Condition: Acute HIV Infection
Interventions: Drug: cART(TDF/AZT+3TC+LPV/r);   Procedure: CTL infusion
3 Completed Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral Therapy
Conditions: HIV;   HIV Infections
Intervention: Behavioral: pharmaceutical care
4 Active, not recruiting Neurobehavioral Model of HIV in Injection Drug Users
Conditions: Drug Abuse;   HIV Infections
Intervention: Other: Injection and Non-Injection Drug Users
5 Completed Efficacy of HIV Post-Test Support for ANC in South Africa
Conditions: HIV;   Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Enhanced Counseling;   Behavioral: Standard of Care
6 Unknown  Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Abacavir sulfate;   Drug: Nelfinavir mesylate;   Drug: Lamivudine;   Drug: GW433908
7 Unknown  A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients
Conditions: HIV Infections;   Hepatitis B Virus
Intervention:
8 Completed Determining Characteristics and Behaviors of Adolescent Women Regarding HIV Risk and Microbicide Trial Participation
Condition: HIV Infections
Intervention:
9 Recruiting Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone
Conditions: Opiate Dependence;   Human Immunodeficiency Virus
Interventions: Drug: injectable naltrexone;   Drug: placebo comparator
10 Completed An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects
Conditions: HIV Infections;   Metabolism, Lipids
Intervention: Drug: nevirapine
11 Terminated The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants
Condition: HIV Infections
Interventions: Drug: Anti-HIV Immune Serum Globulin (Human);   Drug: Zidovudine
12 Completed A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3
Condition: HIV Infections
Intervention: Drug: Adefovir dipivoxil
13 Completed TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: Rifabutin
14 Completed The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient
Condition: HIV Infections
Interventions: Drug: Oxazepam;   Drug: Zidovudine
15 Completed Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection
Condition: HIV Infections
Interventions: Biological: MRKAd5 HIV-1 gag/pol/nef;   Biological: MRKAd5 HIV-1 gag/pol/nef placebo
16 Terminated Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy
Conditions: HIV Infection;   Malaria
Intervention: Drug: Artemether/Lumefantrine (AL)
17 Recruiting Prospective Observational Epidemiologic Study of Maraviroc's Safety
Condition: Human Immunodeficiency Virus
Interventions: Drug: Maraviroc along with an optimized background antiretroviral drug regimen;   Drug: Optimized background antiretroviral drug regimen without maraviroc
18 Completed The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-Infected Pregnant Women.
Condition: HIV Infections
Intervention: Drug: Saquinavir and Ritonavir
19 Completed A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy
Conditions: Lymphatic Disease;   HIV Infections
Intervention: Drug: Inosine pranobex
20 Completed Hepatitis B Vaccination in HIV-infected Persons
Conditions: HIV Infections;   Hepatitis B
Intervention: Biological: HBVAXPRO, Hepatitis B (Recombinant) vaccine, 10 mcg/ml

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years